Plasminogen activator inhibitor-1 - Wikipedia
GenoType PAI-1 | Detection of polymorphisms in PAI-1 gene
Role of PAI-1 in hepatic steatosis and dyslipidemia | Scientific Reports
PERIOD2 is a circadian negative regulator of PAI-1 gene expression in mice - Journal of Molecular and Cellular Cardiology
Endothelial PAI-1 (Plasminogen Activator Inhibitor-1) Blocks the Intrinsic Pathway of Coagulation, Inducing the Clearance and Degradation of FXIa (Activated Factor XI) | Arteriosclerosis, Thrombosis, and Vascular Biology
Structure of PAI-1 gene showing site of 4G/5G polymorphism 675bp... | Download Scientific Diagram
Frontiers | Targeting PAI-1 in Cardiovascular Disease: Structural Insights Into PAI-1 Functionality and Inhibition
Association of the plasminogen activator inhibitor-1(PAI-1) gene 4G/5G promoter polymorphism in Buerger's disease (Tromboangiitis obliterans)
Role of PAI-1 in hepatic steatosis and dyslipidemia | Scientific Reports
Schematic representation of PAI-1 promoter, showing the 4G/5G single... | Download Scientific Diagram
Plasminogen activator inhibitor-1 (PAI-1) deficiency
Complete plasminogen activator inhibitor 1 deficiency: MedlinePlus Genetics
IJMS | Free Full-Text | PAI-1, the Plasminogen System, and Skeletal Muscle
PAI-1/SERPINE1 siRNA (r), shRNA and Lentiviral Particle Gene Silencers | SCBT - Santa Cruz Biotechnology
Figure 2 from Plasminogen activator inhibitor-1 gene polymorphisms in pre-eclampsia. | Semantic Scholar
A Role for Plasminogen Activator Inhibitor-1 in Obesity: From Pie to PAI? | Arteriosclerosis, Thrombosis, and Vascular Biology
PAI-1 Gene Support Group - 4G/4G, 4G/5G | Facebook
JCI - Interacting hepatic PAI-1/tPA gene regulatory pathways influence impaired fibrinolysis severity in obesity
Figure 1 from Plasminogen activator inhibitor-1 (PAI-1) gene 4G/5G promoter polymorphism is not associated with breast cancer. | Semantic Scholar
Complete Deficiency of Plasminogen-Activator Inhibitor Type 1 Due to a Frame-Shift Mutation | NEJM
PAI-1 gene | Qualitative analysis Synevo
Drug Targeting of Plasminogen Activator Inhibitor-1 Inhibits Metabolic Dysfunction and Atherosclerosis in a Murine Model of Metabolic Syndrome | Arteriosclerosis, Thrombosis, and Vascular Biology
Role of PAI-1 in hepatic steatosis and dyslipidemia | Scientific Reports
